← Back to CGTX

Cognition Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 07/08/2026Sep 2025Filed 06/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 07/08/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/11/2025Mar 2024Filed 06/11/2025
−$3.9−$4.6−$4.9−$6.7−$8.5−$9.9−$7−$9.2
−$0.04−$0.05−$0.06−$0.11−$0.14−$0.25−$0.18−$0.27
9189786462404034

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.